Choueiri et al. (20) identified BRAF V600E mutations in 26 of 29 MA cases, providing the first evidence that BRAF V600E mutations are present in 90% of MA cases and can be used as a potential diagnostic tool. This evidence concerns the gene BRAF and microtia.